Where does Apos Medical Assets Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apos Medical Assets Ltd. ranks #25,755 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apos Medical Assets Ltd. hold?

Apos Medical Assets Ltd. holds 10 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is Apos Medical Assets Ltd.'s Innovation Score?

Apos Medical Assets Ltd. has an Innovation Score of 41.4 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Apos Medical Assets Ltd. focus on?

Apos Medical Assets Ltd.'s top technology area is A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear) with 8 patents, ranking #44 of 317 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Apos Medical Assets Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Apos Medical Assets Ltd..

What does claim depth mean for Apos Medical Assets Ltd.'s patents?

Apos Medical Assets Ltd.'s patents average 7.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apos Medical Assets Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Apos Medical Assets Ltd.

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apos ranks #25,755 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#25,755
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.4/100): 7.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R25755 · Foreign Corporation #25,755 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #25,755/49,997
PHOTO-FINISH AOptix
CPC-NARROW A43B · 6 areas
INNOV-PAR 41.4/100
CLAIMS-SPARSE 7.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: AOptix Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apos’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (20%) Velocity 20.0 pts (48%) Breadth 8.7 pts (21%) Claim depth 4.5 pts (11%)

Qualcomm Incorporated · highest

85
Apos Medical Assets · this assignee

41
3D Lighting… · lowest

7

What this shows Apos's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apos?

Each dot is one of Apos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apos’s own 7.5 claims/patent is at or below the 19.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Apos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apos's grants concentrate

Apos Medical Assets Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear). Peak complete grant year is 2024 (4 grants) versus a trough of 2 in 2020. By volume, Apos sits between AOptix Technologies, Inc. and Aquahydrex PTY Ltd.

Apos's three-year grant acceleration

Apos Medical Assets Ltd. shows 7 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aoptix

10
Apana

10
APEM

10
Aphp (Assistance…

10
Applied Vision

10
Apton Biosystems

10
Aqua BIO Technolo…

10
Aquahydrex PTY

10
Apos Medical Asse… ◀

10

What this shows Apos holds 10 patents at rank #25,696, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apos

By rank, the assignees closest to #25,696 in granted patent volume.

Leaders in A43B (Characteristic Features OF Footwear)

Other assignees with the most granted patents in Apos's primary technology class.

Apos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Apos Medical Assets Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	20.0%
2022	3	30.0%
2024	4	40.0%
2025partial year	1	10.0%

Which technologies does Apos Medical Assets Ltd. patent most?

A43B - Characteristic Features OF FOOTWEAR; Parts OF Footwear 8

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 5

A61B - DIAGNOSIS; SURGERY; Identification 4

A43C - Fastenings OR Attachments OF FOOTWEAR; Laces IN General 1

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apos Medical Assets Ltd.'s patent record in context - here's where to go next.

Apos Medical Assets Ltd.'s lead technology class is A43B (Characteristic Features OF FOOTWEAR; Parts OF Footwear), 80% of its portfolio - see every assignee active in that class. Explore A43B
Ranked #25,755 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apos Medical Assets Ltd. against AOptix Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.